tamoxifen oncology
Selected indexed studies
- The tamoxifen controversy. (Oncol Nurs Forum, 1996) [PMID:8792346]
- Tamoxifen: an overview of recent studies in the field of oncology. (Cancer Treat Rep, 1980) [PMID:7000349]
- American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. (J Clin Oncol, 1999) [PMID:10561236]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The tamoxifen controversy. (1996) pubmed
- Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications. (2015) pubmed
- Tamoxifen in men: a review of adverse events. (2016) pubmed
- Tamoxifen: an overview of recent studies in the field of oncology. (1980) pubmed
- American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. (1999) pubmed
- American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition. (2002) pubmed
- The effect of tamoxifen on the endometrium. (1995) pubmed
- Tamoxifen-induced acute mania: A case report. (2020) pubmed
- American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. (2009) pubmed
- Influence of tamoxifen on ocular morphology and function. (2025) pubmed